4//SEC Filing
Gamelin Erick 4
Accession 0000905148-24-003291
CIK 0001781174other
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 6:08 PM ET
Size
5.2 KB
Accession
0000905148-24-003291
Insider Transaction Report
Form 4
Gamelin Erick
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-03-01+45,045→ 45,045 totalExercise: $5.70Exp: 2034-02-28→ Common Stock (45,045 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2025, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date.
Documents
Issuer
Acrivon Therapeutics, Inc.
CIK 0001781174
Entity typeother
Related Parties
1- filerCIK 0001950551
Filing Metadata
- Form type
- 4
- Filed
- Nov 26, 7:00 PM ET
- Accepted
- Nov 27, 6:08 PM ET
- Size
- 5.2 KB